S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2016-03	Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Uttenreuther-Fischer, Martina; Xu, Binghe; Piccart-Gebhart, Martine The Lancet Oncology, Vol.17 No.3, pp.357-366	DOI
2020-05	Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Wells, Athol U.; Flaherty, Kevin R.; Brown, Kevin K.; Inoue, Yoshikazu; Devaraj, Anand; Richeldi, Luca; Moua, Teng; Crestani, Bruno; Wuyts, Wim A.; Stowasser, Susanne; Quaresma, Manuel; Goeldner, Rainer-Georg; Schlenker-Herceg, Rozsa; Kolb, Martin; Trial Investigators; Park, Jong Sun The Lancet Respiratory Medicine, Vol.8 No.5, pp.453-460	DOI